Though strides have been made in treating sickle cell retinopathy over the years, there’s still far to go.
Experts review the pros and cons of the newest imaging devices available for the retina specialist.
A look at the drugs and devices closest to the clinical-trial finish line in the United States.
A comprehensive look at how other retina specialists repair detachments can help inform your technique.
The authors break down the current approach to training in ophthalmology in general—and retina in particular.
Surgeons delve into the pros and cons of a variety of vitreoretinal surgical viewing technologies.
How to best tap into government assistance, manage staff, carefully increase office visits and return to a more regular surgical schedule.
A look at the drug therapies that may eventually bear fruit against a disease that has resisted previous attempts at treatment.
A look at both the potential benefits—and possible drawbacks—of artificial intelligence.
These new additions to the OCT arena may help with surgical maneuvers, but new research could improve them further.